Results of Operations and Financial Condition
Show detailsHide details
2.02 Results of Operations and Financial Condition
4d Molecular Therapeutics, Inc.
A maker of genetic medicines, 4D Molecular Therapeutics engineers custom viral delivery vehicles to treat diseases of the eye, lung, and heart. Founded in 2013 by a UC Berkeley professor and a biotech entrepreneur who met at a university innovation hub, the company got its start in a garage incubator. Its name reflects the four dimensions of optimization its scientists pursue when designing the adeno-associated virus vectors that carry therapeutic genes into the body.
2.02 Results of Operations and Financial Condition
8.01 Other Events
1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
5.07 Submission of Matters to a Vote of Security Holders
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
3.02 Unregistered Sales of Equity Securities · 9.01 Financial Statements and Exhibits